EUVIMEDEUVIMED entdecken
Crossref

The Epidemiological Landscape of Thyroid Cancer and Estimates of Overdiagnosis in China: A Population-Based Study

Qixun Zhu, Junli Liu, Junrong Hu, Yanting Zhang iD

Thyroid® · 01.03.2025 · 35 (3) · 307-320

DOI: 10.1089/thy.2024.0583 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Thyroid®, erschienen am 01.03.2025. Verfasst von Qixun Zhu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epidemiology and Health Statistics, School of Public Health, Guangdong Medical University, Dongguan, China. Hauptthemen laut MEDLINE: Thyroid Neoplasms, Overdiagnosis. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 46 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Thyroid NeoplasmsOverdiagnosisHumansFemaleMaleMiddle AgedChinaAdultAgedAdolescentIncidenceYoung AdultAged, 80 and overMedical Overuse

Stichwörter der Autor:innen

Chinaepidemiologyoverdiagnosisthyroid cancer

Autor:innen und Institutionen

  • Department of Epidemiology and Health Statistics, School of Public Health, Guangdong Medical University, Dongguan, China.

ORCID-Profile: Yanting Zhang

Zitieren

APA

Zhu, Q., Liu, J., Hu, J., & Zhang, Y. (2025). The Epidemiological Landscape of Thyroid Cancer and Estimates of Overdiagnosis in China: A Population-Based Study. Thyroid®, 35(3), 307-320. https://doi.org/10.1089/thy.2024.0583

Vancouver

Zhu Q, Liu J, Hu J, Zhang Y. The Epidemiological Landscape of Thyroid Cancer and Estimates of Overdiagnosis in China: A Population-Based Study. Thyroid®. 2025;35(3):307-320. doi:10.1089/thy.2024.0583

BibTeX
@article{Zhu2025,
  author = {Zhu, Qixun and Liu, Junli and Hu, Junrong and Zhang, Yanting},
  title = {The Epidemiological Landscape of Thyroid Cancer and Estimates of Overdiagnosis in China: A Population-Based Study},
  journal = {Thyroid®},
  year = {2025},
  volume = {35},
  number = {3},
  pages = {307--320},
  doi = {10.1089/thy.2024.0583}
}
Kostenlos starten →